1952 Nobel Prize in Physiology or Medicine — Waksman, Streptomycin, and the First Weapon Against Tuberculosis

What You Will Learn in This Article

This article explores how Waksman systematically screened the largely unexplored library of soil actinomycetes to discover streptomycin, why this discovery marked a turning point in tuberculosis treatment, and the enduring questions about academic credit raised by the dispute with Albert Schatz, the graduate student who actually isolated the strain.

A Different Perspective — The Era When Tuberculosis Was a Disease of the Young

We often imagine tuberculosis as a "disease of the past." This is a perspective from the late 20th century. In the world up to 1950, tuberculosis was one of the leading causes of death among young people, and a persistent source of mass mortality, especially in urban slums. In Korea, the mortality rate from pulmonary tuberculosis was also extremely high during this period, and it was a recurring cause of premature death among famous artists and intellectuals (the poet Yun Dong-ju also died of a tuberculosis-related illness).

Penicillin (1945 Nobel Prize) was ineffective against tuberculosis. Tuberculosis is caused by bacteria in the Mycobacterium genus, which have unique characteristics (acid-fastness) in Gram staining, and their cell wall structure, the target of penicillin, is inaccessible to the drug. Even after the advent of the penicillin era, tuberculosis remained a largely incurable disease.

This situation was reversed by the discovery of streptomycin in Waksman's laboratory in 1943. The drug binds to the ribosomes of the tuberculosis bacterium, inhibiting protein synthesis. It targeted a different, previously unexplored target, bypassing the bacterium's unique cell wall. It was the first weapon in the fight against tuberculosis that actually had a significant impact.

The Landscape of the Times — Tuberculosis in the Early Cold War

1952 was the year when the Korean War was in a truce negotiation phase. In March, Eisenhower was nominated as a presidential candidate, and in November, he was elected. In the Soviet Union, Stalin's reign was coming to an end (he died in March of the following year). The United States successfully conducted its first hydrogen bomb test at Bikini Atoll in November, ushering in a new phase of the Cold War.

During this period, tuberculosis was a chronic problem for soldiers in the Korean War. Prolonged field life, malnutrition, and crowded living conditions created the perfect environment for the spread of tuberculosis, and the US military medical corps began to use streptomycin extensively. As its effectiveness became apparent, its use accelerated and spread around the world. Data from Korean War casualties contributed to the early accumulation of streptomycin clinical protocols during this period.

If we look at it in the context of Korean history, 1952 was the year of the Busan political upheaval. It was the time when Syngman Rhee secured his power base by virtually neutralizing the National Assembly. While a drug that could cure tuberculosis was being put into practical use in other parts of the world, the Korean peninsula was experiencing war and political turmoil, which delayed the development of infrastructure.

Waksman — The Pioneer of Soil Microbiology

Selman Abraham Waksman was a Jewish man born in Russia. He grew up in a Jewish village in Ukraine and immigrated to the United States in his early twenties in 1910. He received training at Rutgers University and spent most of the rest of his life at the university's soil microbiology department.

His research focused on soil actinomycetes. Actinomycetes are microorganisms that resemble fungi in that they extend hyphae, but they are actually closer to bacteria. They include those that produce geosmin, the substance responsible for the smell of soil. By the 1930s, Waksman was already the world's leading authority on the taxonomic classification of soil actinomycetes.

Around 1939, he began a project to systematically screen for antimicrobial substances. After Fleming's discovery of penicillin (1928) became known in the academic community, Waksman hypothesized that soil actinomycetes would possess large quantities of such substances. One of the facts he had observed for a long time—that pathogens do not survive for long in soil—was the basis for this hypothesis. He believed that actinomycetes in the soil secrete large amounts of substances that inhibit each other.

In the language of computer science, his project can be described as a systematic search of a large open-source library. The soil contains tens of thousands of species of actinomycetes, and each species can produce its own set of compounds. He hypothesized that some of these compounds would be clinically useful antibiotics, and he began to search for them one species at a time.

The Discovery of Streptomycin and the Credit Dispute

In 1943, Waksman's graduate student, Albert Schatz, discovered the key strain. A specific strain of Streptomyces griseus, an actinomycete, produced a potent antimicrobial substance that killed the tuberculosis bacterium. This substance was streptomycin.

Animal experiments were conducted immediately, followed by the first clinical trials in 1944. The results were remarkable. Tuberculosis patients actually began to recover. This drug opened a door that penicillin had not. Large-scale production began in 1945, and in the following years, the global mortality rate from tuberculosis dropped dramatically.

This is where the long-standing academic dispute began. Waksman secured a significant portion of the patent rights for streptomycin through a contract with Rutgers University and received large royalties. Schatz, the graduate student who actually isolated the strain, was initially excluded from the negotiations for patent rights. In 1949, Schatz sued Waksman and eventually obtained a portion of the royalties (about 3%) and co-discoverer status. However, in 1952, the Nobel Prize was awarded solely to Waksman.

The debate about this outcome has continued in the academic community. Was the Nobel Committee's judgment correct? How should credit be shared between a professor and a graduate student? There is still no clear answer to this question, but the Waksman-Schatz case remains a classic example of academic credit politics today.

In the world of computer science, similar questions arise. The practice of graduate students or junior developers writing crucial code and the professor or senior being listed as the primary author of a paper remains controversial. The question of who is the true owner of a discovery remains largely unresolved within the hierarchical structure of academia.

The Long War Against Tuberculosis

Streptomycin did not completely eradicate tuberculosis. Within a few years, resistant strains began to emerge, and tuberculosis recurred in patients treated with the drug alone. This led to the development of combination therapy. Streptomycin + PAS (para-aminosalicylic acid), and later + isoniazid (1952), and so on. Using multiple drugs at the same time reduces the probability of resistance, and this is the principle behind combination therapy.

This approach is still the standard for tuberculosis treatment today. The WHO's DOTS (directly observed therapy short-course) program uses a 4-5 drug combination to manage tuberculosis, and second-line drugs are used in a tiered manner to combat drug-resistant tuberculosis (MDR-TB, XDR-TB).

From a computer science perspective, this approach is defense in depth. It involves combining multiple layers of defense instead of relying on a single layer, in order to reduce the overall probability of failure. The story that began with streptomycin has led to a multi-layered architecture for tuberculosis treatment.

The Word "Antibiotic"

Waksman's other legacy is that he introduced the term "antibiotic" to the academic community in 1941. The etymology of the word is Greek (anti + biosis, "against life"), and he established this term as the academic standard for "a substance produced by one microorganism that inhibits or kills another microorganism."

Why is the creation of this term important? Once a category is created, new cases that fall within that category are naturally organized. After the term "antibiotic" was established, drugs such as streptomycin, chloramphenicol, erythromycin, and vancomycin were incorporated into this category and compared and classified. This is an example of the power of academic language.

This approach is repeated in the world of computer science. Every time terms such as "operating system," "microservice," "container," and "large language model" become established, the cases that fall under them are organized. The creation of a category enables the expansion of knowledge, and Waksman's creation of the antibiotic term is an example of this.

Why It Matters

Waksman's story leaves us with three lessons.

Scientifically, he established the prototype of the natural product screening method for new drug development. In the decades that followed, this approach led to the discovery of many antibiotics, anticancer drugs, and immunosuppressants. Although natural product drug development has relatively stagnated in recent years, it is being revitalized by the combination with AI-based screening.

Clinically, streptomycin and its successor drugs were the crucial tools that dramatically reduced tuberculosis mortality in the latter half of the 20th century. The fact that we recognize tuberculosis as a "curable disease" today is a legacy of Waksman's work.

Philosophically, the questions raised by his credit dispute remain unresolved in both academia and industry today. Who owns the discovery? The tension between the professor and the graduate student, the individual and the organization, the discoverer and the patent holder, was clearly manifested in the Waksman-Schatz case and continues to this day.

The Nobel Committee's award was a recognition of the decisive victory achieved by humanity in the fight against tuberculosis, but the way in which that recognition was given also highlighted the dark corners of academia.

1952 Waksman Summary: Discovery of streptomycin from soil actinomycete (Streptomyces griseus) in 1943, established as the first antibiotic for tuberculosis treatment. Coined the term "antibiotic" in 1941, established the prototype of the actinomycete screening method. The credit dispute with graduate student Albert Schatz remains an academic legacy.

→ Previous: 1951 — Theiler and Yellow Fever Vaccine → Next: 1953 — Krebs and Lipmann